Skip to main content
Equibles
RNXT logo

RNXT · RenovoRx, Inc.

Track RNXT — free

Use RNXT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RNXT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.20 -0.20 (-14.29%)
Market Cap
$63.18M
Shares
45.13M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.40 Open$1.27 Day$1.26–1.45 52W close$0.73–1.40 Avg vol 30d319K Short int283K · 0.6% float · 1.4d Short vol26% Last earningsAug 12, 2026 DataAug 2021–Aug 2026 Filing10-Q · Aug 13

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Buy
      50 / 200-day cross Golden cross
      Price vs 200-day avg +49%
      above
      Price vs 50-day avg +47%
      above
      RSI (14) 79
      overbought
      MACD trend Positive
      52-week position 100%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +62%
      trailing
      6-month return +55%
      trailing
      YTD return +67%
      this year
      Relative strength +41%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) Golden cross
      50d $1 › 200d $1 — 50d above 200d
      Institutional flow Distributing
      -6% holders QoQ · +4 funds added
      Insider flow Accumulating
      Net +$19.7K over 90 days · 0% sells
      Short interest Falling
      0.63% of float · ▼ -13.6% MoM · 1.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      29 holders — mid 3-yr range
      Squeeze score 64
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +2512%
      Y/Y
      Gross margin 71%
      contracting
      EPS growth +20%
      Y/Y
      Free cash flow $-11.0M
      Balance sheet $7.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 83%
      annualized · 1-yr
      Max drawdown −45%
      past year
      ATR 6.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Aug 12, 2026
      Full year 2026 revenue · full year 2026 Initiated $3.75M – $4.25M
      prior FY $1.12M midpoint +256.2% Y/Y

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      1 · 1 · 5
      50 / 200-day cross
      Golden cross Bullish
      Price vs 200-day avg
      +49% Bullish
      Price vs 50-day avg
      +47% Bullish
      RSI (14)
      79 Bearish
      MACD trend
      Positive Bullish
      52-week position
      100% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) Golden cross
      50d $1 › 200d $1 — 50d above 200d
      Institutional flow Distributing
      -6% holders QoQ · +4 funds added
      Insider flow Accumulating
      Net +$19.7K over 90 days · 0% sells
      Short interest Falling
      0.63% of float · ▼ -13.6% MoM · 1.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      29 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 100% Range high $1
      vs 200-day avg +49% vs 50-day avg +47% 50-day above 200-day golden cross

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Active commercial cancer centers 16 Q1 2026 —
      Patients randomized in TIGeR-PaC trial 106 Q1 2026 —
      Total cancer centers (active + evaluating/preparing for activation) 48 Q1 2026 —
      Active U.S. cancer centers utilizing RenovoCath 12 as of February 27, 2026 —
      Additional cancer centers evaluating, having completed evaluation, or preparing for activation 21 as of February 27, 2026 —
      Cash on hand $13M as of March 30, 2026 —
      Events (deaths) observed in TIGeR-PaC trial 72 as of March 24, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RNXT
      RenovoRx, Inc.
      this stock
      		$63.18M +66.7% +2511.6% — 0.6%
      ONC
      BeOne Medicines Ltd.
      		 $513.62B +14.4% +22179.2% 789.7 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $128.19B +11.6% +46.2% 29.5 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $82.72B +4.1% +20.8% 19.9 3.3%
      ARGX
      Argenx SE
      		 $52.94B +1.2% — — 2.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      29
      % held
      20.4%
      Net QoQ
      +634.3K sh
      Top holder
      AIGH Capital Management L…
      Held Float
      View
      Held by Funds
      Fund positions
      7
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      283.4K
      Days to cover
      1.4d
      Change
      -44.4K sh
      View
      Short Volume
      Short vol %
      26%
      As of
      Aug 17, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      7.2K
      Value
      $6.3K
      As of
      Jul 17, 2026
      View
      Off-Exchange
      Off-exchange %
      64.1%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$19.7K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $1.1M
      Net income (FY)
      $-11.2M
      EPS diluted
      $-0.32
      View
      Filings
      SEC Filings
      Latest
      8-K/A
      Filed
      Aug 13, 2026
      This year
      19
      View
      Exempt Offerings
      Offering
      $10.0M
      Filed
      Apr 9, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 12, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      RNXT +25.0% +61.9% +55.2% +46.1% +66.7%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +24.6% +57.4% +41.4% +42.2% +52.8%
      Key facts CIK 1574094 CUSIP 75989R107 13F (30d) 27 filings 27 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)